278 related articles for article (PubMed ID: 25288142)
1. Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia.
Schultz CL; Mitra N; Schapira MM; Lambert MP
JAMA Pediatr; 2014 Oct; 168(10):e142214. PubMed ID: 25288142
[TBL] [Abstract][Full Text] [Related]
2. Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals.
Kime C; Klima J; Rose MJ; O'Brien SH
Pediatrics; 2013 May; 131(5):880-5. PubMed ID: 23569091
[TBL] [Abstract][Full Text] [Related]
3. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica.
De Mattia D; Del Principe D; Del Vecchio GC; Jankovic M; Arrighini A; Giordano P; Menichelli A; Mori P; Zecca M; Pession A
Haematologica; 2000 Apr; 85(4):420-4. PubMed ID: 10756369
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines.
Witmer CM; Lambert MP; O'Brien SH; Neunert C
Pediatr Blood Cancer; 2016 Jul; 63(7):1227-31. PubMed ID: 26929009
[TBL] [Abstract][Full Text] [Related]
6. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP].
Le Meignen M; Mossler P; Mates M; Mathey C; Hass A; Monpoux F; Faverge B; Fortier G; Nguyen J; Belahbib L; Coache C; Chamoulli JM; Moulène E; Sirvent N; Michel G; Chambost H
Arch Pediatr; 2008 Sep; 15(9):1398-406. PubMed ID: 18676127
[TBL] [Abstract][Full Text] [Related]
7. Successful implementation of a watchful waiting strategy for children with immune thrombocytopenia.
Bekker E; Rosthøj S
Dan Med Bull; 2011 Apr; 58(4):A4252. PubMed ID: 21466762
[TBL] [Abstract][Full Text] [Related]
8. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.
Revel-Vilk S; Yacobovich J; Frank S; Ben-Ami T; Yechieli M; Shkalim V; Lebel A; Semo-Oz R; Tamary H
J Pediatr; 2013 Nov; 163(5):1335-9.e1-2. PubMed ID: 23891349
[TBL] [Abstract][Full Text] [Related]
9. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis.
Cirasino L; Robino AM; Cattaneo M; Pioltelli PE; Pogliani EM; Terranova L; Morra E; Colombo P; Palmieri GA; Piscitelli P
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):77-84. PubMed ID: 19858712
[TBL] [Abstract][Full Text] [Related]
10. A nationwide survey of newly diagnosed childhood idiopathic thrombocytopenic purpura in Japan.
Shirahata A; Fujisawa K; Ishii E; Ohta S; Sako M; Takahashi Y; Taki M; Mimaya J; Kubota M; Miura T; Kitazawa J; Kajiwara M; Bessho F
J Pediatr Hematol Oncol; 2009 Jan; 31(1):27-32. PubMed ID: 19125083
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
12. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany.
Sutor AH; Harms A; Kaufmehl K
Semin Thromb Hemost; 2001 Jun; 27(3):253-67. PubMed ID: 11446659
[TBL] [Abstract][Full Text] [Related]
13. Treatment of immune thrombocytopenic purpura in children : current concepts.
Shad AT; Gonzalez CE; Sandler SG
Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic thrombocytopenic purpura: a 15-year natural history study at the Children's Hospital Rijeka, Croatia.
Roganovic J; Letica-Crepulja M
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):662-4. PubMed ID: 16933251
[TBL] [Abstract][Full Text] [Related]
15. Bleeding severity as an important outcome in childhood immune thrombocytopenia.
Flores A; Buchanan GR
Pediatr Blood Cancer; 2013; 60 Suppl 1():S8-11. PubMed ID: 23109508
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.
Chotsampancharoen T; Sripornsawan P; Duangchoo S; Wongchanchailert M; McNeil E
Pediatr Blood Cancer; 2017 Jan; 64(1):128-134. PubMed ID: 27571705
[TBL] [Abstract][Full Text] [Related]
17. Immune thrombocytopenic purpura in pregnancy.
Gernsheimer T; McCrae KR
Curr Opin Hematol; 2007 Sep; 14(5):574-80. PubMed ID: 17934366
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
[TBL] [Abstract][Full Text] [Related]
19. Acute immune thrombocytopenic purpura in children and adolescents in South Dakota 1998-2004.
Tancabelic J; Stout LA; Wetering J
S D J Med; 2005 Nov; 58(11):465-8. PubMed ID: 16502732
[TBL] [Abstract][Full Text] [Related]
20. Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines: assessment of Italian experience.
Del Vecchio GC; De Santis A; Giordano P; Amendola G; Baronci C; Del Principe D; Nobili B; Jankovic M; Ramenghi U; Russo G; Zecca M; De Mattia D;
Acta Haematol; 2008; 119(1):1-7. PubMed ID: 18176072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
